Tags

Type your tag names separated by a space and hit enter

Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic.
Scand J Rheumatol. 2010 Aug; 39(4):310-7.SJ

Abstract

OBJECTIVE

To estimate the annual incidence and prevalence of psoriatic arthritis (PsA), ankylosing spondylitis (AS), and reactive arthritis (ReA) in a sample of the Czech population.

METHODS

The population-based study was conducted in two regions of the Czech Republic (with a total population of 186000 inhabitants) in 2002-2003. Incident cases were registered on condition of confirming a definite diagnosis according to existing classification criteria during the study period (1 March 2002 to 1 March 2003). Prevalence was studied on the basis of identification of established diagnoses (before 1 March 2002) from registers of living patients of participating rheumatologists and other specialists. The age-standardized estimates of incidence and prevalence were calculated using the European standard population.

RESULTS

The total annual incidence of PsA in adults aged >or= 16 years was 3.6/100000 [95% confidence interval (CI) 1.4-7.6/100000] and the prevalence of PsA was 49.1/100000 (95% CI 39.5-60.4/100000). The annual incidence of AS in adults was 6.4/100000 (95% CI 3.3-11.3/100000) and the prevalence of AS was 94.2/100000 (95% CI 80.8-109.2/100 000). The annual incidence of ReA in adults was 9.3/100000 (95% CI 5.5-14.8/100000) and the prevalence of ReA was 91.3/100000 (95% CI 78.1-106.2/100000).

CONCLUSION

The annual incidence and prevalence rates of PsA, AS, and ReA in the first population-based survey in the Czech Republic compared well with data reported from other countries.

Authors+Show Affiliations

Institute of Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Czech Republic.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

20476864

Citation

Hanova, P, et al. "Incidence and Prevalence of Psoriatic Arthritis, Ankylosing Spondylitis, and Reactive Arthritis in the First Descriptive Population-based Study in the Czech Republic." Scandinavian Journal of Rheumatology, vol. 39, no. 4, 2010, pp. 310-7.
Hanova P, Pavelka K, Holcatova I, et al. Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic. Scand J Rheumatol. 2010;39(4):310-7.
Hanova, P., Pavelka, K., Holcatova, I., & Pikhart, H. (2010). Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic. Scandinavian Journal of Rheumatology, 39(4), 310-7. https://doi.org/10.3109/03009740903544212
Hanova P, et al. Incidence and Prevalence of Psoriatic Arthritis, Ankylosing Spondylitis, and Reactive Arthritis in the First Descriptive Population-based Study in the Czech Republic. Scand J Rheumatol. 2010;39(4):310-7. PubMed PMID: 20476864.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic. AU - Hanova,P, AU - Pavelka,K, AU - Holcatova,I, AU - Pikhart,H, PY - 2010/5/19/entrez PY - 2010/5/19/pubmed PY - 2010/8/14/medline SP - 310 EP - 7 JF - Scandinavian journal of rheumatology JO - Scand J Rheumatol VL - 39 IS - 4 N2 - OBJECTIVE: To estimate the annual incidence and prevalence of psoriatic arthritis (PsA), ankylosing spondylitis (AS), and reactive arthritis (ReA) in a sample of the Czech population. METHODS: The population-based study was conducted in two regions of the Czech Republic (with a total population of 186000 inhabitants) in 2002-2003. Incident cases were registered on condition of confirming a definite diagnosis according to existing classification criteria during the study period (1 March 2002 to 1 March 2003). Prevalence was studied on the basis of identification of established diagnoses (before 1 March 2002) from registers of living patients of participating rheumatologists and other specialists. The age-standardized estimates of incidence and prevalence were calculated using the European standard population. RESULTS: The total annual incidence of PsA in adults aged >or= 16 years was 3.6/100000 [95% confidence interval (CI) 1.4-7.6/100000] and the prevalence of PsA was 49.1/100000 (95% CI 39.5-60.4/100000). The annual incidence of AS in adults was 6.4/100000 (95% CI 3.3-11.3/100000) and the prevalence of AS was 94.2/100000 (95% CI 80.8-109.2/100 000). The annual incidence of ReA in adults was 9.3/100000 (95% CI 5.5-14.8/100000) and the prevalence of ReA was 91.3/100000 (95% CI 78.1-106.2/100000). CONCLUSION: The annual incidence and prevalence rates of PsA, AS, and ReA in the first population-based survey in the Czech Republic compared well with data reported from other countries. SN - 1502-7732 UR - https://www.unboundmedicine.com/medline/citation/20476864/Incidence_and_prevalence_of_psoriatic_arthritis_ankylosing_spondylitis_and_reactive_arthritis_in_the_first_descriptive_population_based_study_in_the_Czech_Republic_ DB - PRIME DP - Unbound Medicine ER -